Education
About Us
Working with TipRanks
Follow Us
Vir Biotechnology (VIR)
NASDAQ:VIR
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 74.20M | $ 86.18M | $ 1.62B | $ 1.10B | $ 67.25M |
| Gross Profit | $ -404.44M | $ -486.65M | $ 994.83M | $ 581.54M | $ 67.25M |
| Operating Income | $ -587.16M | $ -684.30M | $ 833.07M | $ 420.75M | $ -296.98M |
| EBITDA | $ -508.91M | $ -641.64M | $ 839.85M | $ 426.56M | $ -291.54M |
| Net Income | $ -521.96M | $ -615.06M | $ 515.84M | $ 528.58M | $ -298.67M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 905.35M | $ 1.52B | $ 2.40B | $ 708.14M | $ 736.86M |
| Total Assets | $ 1.40B | $ 1.92B | $ 2.80B | $ 1.95B | $ 918.76M |
| Total Debt | $ 97.89M | $ 124.54M | $ 127.97M | $ 137.49M | $ 70.18M |
| Net Debt | $ -125.06M | $ -117.04M | $ -720.66M | $ -210.33M | $ -366.39M |
| Total Liabilities | $ 248.43M | $ 328.82M | $ 724.13M | $ 522.42M | $ 201.91M |
| Stockholders' Equity | $ 1.15B | $ 1.59B | $ 2.08B | $ 1.43B | $ 716.85M |
| Cash Flow | |||||
| Free Cash Flow | $ -453.65M | $ -800.36M | $ 1.60B | $ -69.41M | $ -197.49M |
| Operating Cash Flow | $ -446.35M | $ -778.78M | $ 1.66B | $ -47.59M | $ -190.94M |
| Investing Cash Flow | $ 499.37M | $ 164.73M | $ -1.19B | $ -140.81M | $ -9.86M |
| Financing Cash Flow | $ 4.39M | $ 7.38M | $ 34.76M | $ 100.33M | $ 529.47M |